Seminal Hemostatic Factors: Then and Now

ABSTRACT

Human semen spontaneously coagulates and subsequently liquefies following ejaculation. The exact reasons for this phenomenon are not entirely understood. Research has resulted in the discovery of several seminal proteins that are already known from another major domain of human physiology (i.e., blood coagulation and fibrinolysis). Some believe that regulation of seminal coagulation and fibrinolytic liquefaction may bear analogies to the well-described pathways operational in blood. We here attempt to summarize the subject, revisiting earlier findings and covering the more recent and extensive data on hemostatically functional seminal proteins, including the findings of our own group. Evidence for the existence of each key hemostatic factor in semen is presented along with any correlation with indices of male fertility. Several probably possess alternative functions including anti-inflammatory action, aiding sperm capacitation and classic hemostasis following intercourse-induced bleeding. Established mechanisms such as the high molecular weight seminal vesicle system are also considered as potentially interacting with conventional hemostatic pathways to regulate seminal coagulation and liquefaction. Although our grasp of this subject continues to evolve, there still remain many unanswered questions. A more complete understanding may one day prove useful in designing technologies for improved diagnostics in male infertility and potentially aiding assisted human reproductive therapies.

Human semen - coagulation - liquefaction - hemostatic factors

REFERENCES

• 1 Masaki J. Biochemistry of semen. In: Mohri H, Morisawa M, Hoshi M Spermatology. Tokyo; University of Tokyo Press 1992: 121-137
• 2 Huggins C, Neal W. Coagulation and liquefaction of semen. Proteolytic enzymes and citrate in prostatic fluid.  J Exp Med. 1942;  76 527-541
• 3 Fareed J, Callas D D, Hoppensteadt D, Bermes Jr E W. Tissue factor antigen levels in various biological fluids.  Blood Coagul Fibrinolysis. 1995;  6(Suppl 1) 32-36
• 4 Fernández J A, Heeb M J, Radtke K-P, Griffin J H. Potent blood coagulant activity of human semen due to prostasome-bound tissue factor.  Biol Reprod. 1997;  56 757-763
• 5 Notides A C, Williams-Ashman H G. The basic proteins responsible for clotting of guinea pig semen.  Proc Natl Acad Sci USA. 1967;  58 1991-1995
• 6 van Wersch J WJ, de Vries-Hanje J C, Ubachs J MH. Coagulation and fibrinolysis markers in seminal plasma of patients under evaluation for involuntary childlessness.  Eur J Clin Chem Clin Biochem. 1992;  30 467-471
• 7 Park J Y, Yoshimara Y, Nozawa S, Umeda T, Akihama S, Matsuda Y. Fibrinogen-like substance and thrombin like enzyme in human seminal plasma: coagulation of human semen.  Arch Androl. 1997;  38 29-36
• 8 Carson S D, de-Jonge C J. Activation of coagulation factor X in human semen.  J Androl. 1998;  19 289-294
• 9 Polak B, Daunter B. Seminal plasma biochemistry. IV: enzymes involved in the liquefaction of human seminal plasma.  Int J Androl. 1989;  12 187-194
• 10 Mandal A, Batabyal S K, Bhattacharyya A K. Glycerylphosphorylcholine levels in the coagulational groups of human ejaculates.  Indian J Med Res. 1989;  90 186-190
• 11 Minhas B S, Kumar R, Ricker D D, Roudebush W E, Dodson M G, Fortunato S J. Effects of platelet activating factor on mouse oocyte fertilization in vitro.  Am J Obstet Gynecol. 1989;  161 1714-1717
• 12 MacGregor I R, Hargreave T B, Elton R A. Seminal plasma plasminogen activator and fertility.  Andrologia. 1987;  19 452-455
• 13 van Dreden P, Gonzales J, Richard P. Determination of tissue plasminogen activator (t-PA) antigen in seminal plasma by modified enzyme-linked immunosorbant assay (ELISA).  Andrologia. 1988;  20 48-51
• 14 van Dreden P, Gonzalez J, Poirot C. Human seminal fibrinolytic activity: specific determinations of tissue plasminogen activator and urokinase.  Andrologia. 1991;  23 29-33
• 15 España F, Gilabert J, Estellés A, Romeu A, Aznar J, Cabo A. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen.  Thromb Res. 1991;  64 309-320
• 16 Lwaleed B A, Greenfield R S, Steward A B, Birch B R, Cooper A J. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system.  Thromb Haemost. 2004;  92 752-766
• 17 Matsuda Y, Shimokawa K, Katayama M et al.. Blood coagulation factor X (FX) in human seminal plasma.  Arch Androl. 2002;  48 295-300
• 18 Lwaleed B A, Greenfield R S, Hicks J, Birch B R, Cooper A J. Quantitation of seminal factor IX and factor IXa in fertile, non-fertile and vasectomy subjects: a step closer towards identifying a functional clotting system in human semen.  J Androl. 2005;  26 146-152
• 19 Lwaleed B A, Greenfield R S, Royle E, Birch B R, Cooper A J. Seminal factor VIII and von Willebrand Factor: a possible role of the conventional clotting system in human semen?.  Int J Androl. 2005;  28 31-38
• 20 Lwaleed B A, Greenfield R S, Birch B R, Cooper A J. Does human semen contain a functional haemostatic system? A possible role for tissue factor pathway inhibitor in fertility through semen liquefaction.  Thromb Haemost. 2005;  93 847-852
• 21 Lwaleed B A, Jackson C, Greenfield R S et al.. Seminal tissue factor revisited.  Int J Androl. 2006;  29 360-367
• 22 Tauber P F, Zaneveld L JD, Propping D, Schumacher G F. A new technique to measure the liquefaction rate of human semen: the bag method.  Fertil Steril. 1980;  33 567-570
• 23 Wetterauer U. Recommended biochemical parameters for routine semen analysis.  Urol Res. 1986;  14 241-246
• 24 Mandal A, Bhattacharyya A K. Grouping of human ejaculates according to the degree of coagulation and the relationship to the levels of choline and cholinesterase.  Int J Androl. 1986;  9 407-415
• 25 Syner F N, Moghissi K S, Yanez J. Isolation of a factor from normal human semen that accelerates dissolution of abnormally liquefying semen.  Fertil Steril. 1975;  26 1064-1069
• 26 Lukac J, Koren E. Mechanism of liquefaction of the human ejaculate. II. Role of collagenase-like peptidase and seminal proteinase.  J Reprod Fertil. 1979;  56 501-506
• 27 Ohta S, Wada H, Gabazza E C, Nobori T, Fuse H. Evaluation of tissue factor antigen level in human seminal plasma.  Urol Res. 2002;  30 317-320
• 28 Laurell M, Christensson A, Abrahamsson P A, Stenflo J, Lilja H. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.  J Clin Invest. 1992;  89(4) 1094-1101
• 29 Laurell M, Christensson A, Abrahamsson P A, Stenflo J, Lilja H. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.  J Clin Invest. 1992;  89 1094-1101
• 30 Bronson R A, Preissner K T. Measurement of vitronectin content of human spermatozoa and vitronectin concentration within seminal fluid.  Fertil Steril. 1997;  68 709-713
• 31 Preissner K T, Seiffert D. Role of vitronectin and its receptors in haemostasis and vascular remodeling.  Thromb Res. 1998;  89 1-21
• 32 Schvartz I, Seger D, Shaltiel S. Vitronectin.  Int J Biochem Cell Biol. 1999;  31 539-544
• 33 Kirchheimer J C, Hienert G, Christ G, Binder B R. Components of the fibrinolytic system in spermatozoa and seminal plasma of fertile and infertile men.  Thromb Haemost. 1989;  62 396 , (abst)
• 34 Williams-Ashman H G, Notides A C, Pabalan S S, Lorand L. Transamidase reactions involved in the enzymic coagulation of semen: isolation of -glutamyl-lysine dipeptide from clotted secretion protein of guinea pig seminal vesicle.  Proc Natl Acad Sci USA. 1972;  69 2322-2325
• 35 Williams-Ashman H G, Wilson J, Beil R E, Lorand L. Transglutaminase reactions associated with the rat semen clotting system: modulation by macromolecular polyanions.  Biochem Biophys Res Commun. 1977;  79 1192-1198
• 36 Tauber P F, Zaneveld L JD, Propping D, Schumacher G FB. Components of human split ejaculates. II. Enzymes and proteinase inhibitors.  J Reprod Fertil. 1976;  46 165-171
• 37 Murakami J, Yoshiike M, Satoh M, Furuichi Y, Iwamoto T. Characterization of recombinant precursor proteins of the human seminal plasma sperm motility inhibitor synthesized in insect cells.  Int J Mol Med. 1998;  2 693-700
• 38 Peter A, Lilja H, Lundwall A, Malm J. Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase.  Eur J Biochem. 1998;  252 216-221
• 39 Chaistitvanich N, Boonsaeng V. Molecular structure of human seminal coagulum: the role of disulfide bonds.  Andrologia. 1983;  15 446-451
• 40 Lilja H, Laurell C B. Liquefaction of coagulated human semen.  Scand J Clin Lab Invest. 1984;  44 447-452
• 41 Lilja H, Laurell C B. The predominant protein in human seminal coagulate.  Scand J Clin Lab Invest. 1985;  45 635-641
• 42 Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.  J Clin Invest. 1985;  76 1899-1903
• 43 Malm J, Hellman J, Hogg P, Lilja H. Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn (2 + ), a tight-binding inhibitor.  Prostate. 2000;  45 132-139
• 44 Laurell C B, Weiber H, Ohlsson K, Rannevik G. A zinc-dependent peptidase in prostatic organelles present in seminal plasma.  Clin Chim Acta. 1982;  126 161-170
• 45 Mann T. The Biochemistry of Semen and of the Male Reproductive Tract. London; Methuen 1984
• 46 Edwards J J, Tollaksen S I, Andersson N G. Proteins of human semen. 1. Two-dimensional mapping of human seminal fluid.  Clin Chem. 1981;  27 1335-1340
• 47 Lilja H, Laurell C B, Jeppsson J O. Characterization of the predominant basic protein in human seminal plasma, one cleavage product of the major seminal vesicle protein.  Scand J Clin Lab Invest. 1984;  44 439-446
• 48 Ronquist G, Brody I. The prostasome: its secretion and function in man.  Biochim Biophys Acta. 1985;  822 203-218
• 49 Brody I, Ronquist G, Gottfries A. Ultrastructural localisation of the prostasome-an organelle in human seminal plasma.  Ups J Med Sci. 1983;  88 63-80
• 50 Thyzel E, Siegling S, Gotting C, Tinneberg H R, Brinkmann T, Kleesiek K. Quantification of tissue factor pathway inhibitor in human seminal plasma and in human follicular fluid.  Thromb Res. 2003;  109 329-332
• 51 Yamamuro M, Wada H, Kumeda K et al.. Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation.  Blood Coagul Fibrinolysis. 1998;  9 491-497
• 52 Moghissi K S, Wallach E E. Unexplained infertility.  Fertil Steril. 1983;  39 5-21
• 53 Elzanaty S, Richthoff J, Malm J et al.. The impact of epididymal and accessory sex gland function on sperm motility.  Hum Reprod. 2002;  17 2904-2911
• 54 Zhao Y, Vlahos N, Wyncott D et al.. Impact of semen characteristics on the success of intrauterine insemination.  J Assist Reprod Genet. 2004;  21 143-148
• 55 Skibinski G, Kelley R W, Harkiss D, James K. Immunosuppression by human seminal plasma-extracellular organelles (prostasomes) modulate activity of phagocytic cells.  Am J Reprod Immunol. 1992;  28 97-103
• 56 Ronquist G, Nilsson B O, Hjertën S. Interaction between prostasomes and spermatozoa from human semen.  Arch Androl. 1990;  24 147-157
• 57 Arienti G, Carlini E, Palmerini C A. Fusion of human sperm to prostasomes at acidic pH.  J Membr Biol. 1997;  155 89-94
• 58 Federici A B. The factor VIII/von Willebrand factor complex: basic and clinical issues (EREP02).  Haematologica. 2003;  88 3-12
• 59 van Hylckama Vlieg A, van der Linden I K, Bertina R M, Rosendaal F R. High levels of factor IX increase the risk of venous thrombosis.  Blood. 2000;  95 3678-3682
• 60 Reiner A P, Davie E W. The physiology and biochemistry of factor IX. In: Bloom AL, Thomas DP Haemostasis and Thrombosis. 3rd ed. Edinburgh; Churchill Livingstone 1994: 309-324
• 61 van Wersch J WJ, Ubachs J HM, Dalaere K PJ. Fibrinolysis and coagulation markers in seminal plasma before and after vasectomy.  Fibrinolysis. 1993;  7 135-138
• 62 Matsuda Y, Oshio S, Yazaki T, Umeda T, Akihama S. The effect of some proteinase inhibitors on liquefaction of human semen.  Hum Reprod. 1994;  9 664-668
• 63 Maier U, Kirchheimer J C, Hienert G, Christ G, Binder B R. Fibrinolytic parameters in spermatozoas and seminal plasma.  J Urol. 1991;  146 906-908
• 64 Zhang G H. Preliminary studies on the role of plasminogen activator in seminal plasma of human and rhesus monkey.  Mol Hum Reprod. 1996;  2 99-104
• 65 Lwaleed B A, Goyal A, Delves G, Greenfield R S, Cooper A J. Quantification of seminal thrombomodulin.  Haematologica. 2006;  91 391(Abst)
• 66 Lwaleed B A, Greenfield R S, Birch B R, Cooper A J. Quantitation of thrombin activatable fibrinolysis inhibitor (TAFI) in human semen.  Br J Haematol. 2005;  129(Suppl 1) 173 (Abst)
• 67 Robert M, Gagnon C. Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein.  Cell Mol Life Sci. 1999;  55 944-960
• 68 Dietl T, Kruch J, Schill W B, Fritz H. Localization of seminal plasma proteinase inhibitors in human spermatozoa as revealed by indirect immunofluorescence technique.  Hoppe Seylers Z Physiol Chem. 1976;  357 1333-1337
• 69 Veselsky L, Jonakova V, Cechova D. A Kunitz type of proteinase inhibitor isolated from boar seminal vesicle fluid.  Andrologia. 1985;  17 352-358
• 70 Hara I, Matsuda Y, Kaneko S et al.. Human seminal plasma proteinase inhibitor: action toward some trypsin-like arginine amidases from humans.  Arch Androl. 1993;  31 23-29
• 71 Rümke P. The origin of immunoglobulins in semen.  Clin Exp Immunol. 1974;  17 287-297